Literature DB >> 18562848

Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?

Junie Barbara Morquette1, Adriana Di Polo.   

Abstract

Glaucoma and other optic neuropathies have been traditionally viewed as diseases of the optic nerve that lead to retinal ganglion cell (RGC) degeneration. Accordingly, the primary aim of neuroprotective strategies has been to preserve RGC axons and soma. RGCs are complex and highly polarized central neurons, and their pathologic response in disease is likely to be an integration of signals from all cellular compartments-axons, soma, dendrites, and synaptic contacts. We focus on the role of dendrites and dendritic spines in normal neuronal function, neurologic disorders, and glaucoma. The need to understand the mechanisms underlying RGC dendrite and synapse degeneration in glaucoma and other optic neuropathies is compelling, as it may provide insight into novel therapeutic strategies to prevent vision loss.

Entities:  

Mesh:

Year:  2008        PMID: 18562848     DOI: 10.1097/WNO.0b013e318177edf0

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  16 in total

1.  Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway.

Authors:  Jun Zheng; Xuemei Feng; Lina Hou; Yongyao Cui; Liang Zhu; Jian Ma; Zheng Xia; Wei Zhou; Hongzhuan Chen
Journal:  Cell Mol Neurobiol       Date:  2011-01-29       Impact factor: 5.046

Review 2.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

Review 3.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

4.  The expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: the expression of myelin proteins in the retina in glaucoma.

Authors:  Xin-Xue Liao; Dong Chen; Jianbo Shi; Yue-Qi Sun; Shu-Juan Sun; Kwok-Fai So; Qing-Ling Fu
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

Review 5.  Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby
Journal:  Exp Eye Res       Date:  2015-06-24       Impact factor: 3.467

6.  Early microglia activation in a mouse model of chronic glaucoma.

Authors:  Alejandra Bosco; Michael R Steele; Monica L Vetter
Journal:  J Comp Neurol       Date:  2011-03-01       Impact factor: 3.215

7.  Synaptic degeneration of retinal ganglion cells in a rat ocular hypertension glaucoma model.

Authors:  Qing-Ling Fu; Xin Li; Jianbo Shi; Geng Xu; Weiping Wen; Daniel H S Lee; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2009-01-27       Impact factor: 5.046

8.  Integrative properties of retinal ganglion cell electrical responsiveness depend on neurotrophic support and genotype in the mouse.

Authors:  Tsung-Han Chou; William J Feuer; Odelia Schwartz; Mario J Rojas; Jennifer K Roebber; Vittorio Porciatti
Journal:  Exp Eye Res       Date:  2015-11-22       Impact factor: 3.467

Review 9.  Who's lost first? Susceptibility of retinal ganglion cell types in experimental glaucoma.

Authors:  Luca Della Santina; Yvonne Ou
Journal:  Exp Eye Res       Date:  2016-06-16       Impact factor: 3.467

10.  AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma.

Authors:  Nicolas Belforte; Jessica Agostinone; Luis Alarcon-Martinez; Deborah Villafranca-Baughman; Florence Dotigny; Jorge L Cueva Vargas; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2021-06-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.